Electrovac: In order to gain a valid impression of the companies' operating performance, boersengefluester.de (BGFL) has summarised the key figures in table form. Where individual figures are still estimates, they are taken from BGFL.
| The most important financial data at a glance | ||||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | |
| Sales1 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 85,25 | 87,62 | 98,16 | 117,00 | 119,00 |
| EBITDA1,2 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 10,33 | 9,20 | 14,69 | 19,60 | 19,40 |
| EBITDA-Margin3 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 12,11 | 10,51 | 14,96 | 16,75 | 16,30 |
| EBIT1,4 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 5,73 | 4,41 | 9,11 | 13,45 | 12,80 |
| EBIT-Margin5 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 6,72 | 5,08 | 9,28 | 11,50 | 10,76 |
| Net Profit (Loss)1 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 3,23 | 1,92 | 5,18 | 8,90 | 8,50 |
| Net-Margin6 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 3,79 | 2,20 | 5,28 | 7,61 | 7,14 |
| Cashflow1,7 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 6,22 | 9,46 | 9,42 | 10,70 | 13,20 |
| Earnings per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,20 | 0,12 | 0,32 | 0,55 | 0,53 |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,15 | 0,15 |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: BDO
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.